Xeno Biosciences

About:

Xeno Biosciences is a biotechnology company that provides novel class of treatments for metabolic diseases.

Website: http://www.xenobiosciences.com

Top Investors: K4 Forum Mumbai Network, ScOp Venture Capital, Bantam Group, Keiretsu Forum, Maine Angels

Description:

Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. It was founded in 2015 and is headquartered in Somerville, Massachusetts.